The effect of Hetastarch (670/0.75) in vivo on platelet closure time in the dog

L. Smart; K.E. Jandrey; P.H. Kass; J.R. Wierenga; F. Tablin

doi:10.1111/j.1476-4431.2009.00464.x

Back

The effect of Hetastarch (670/0.75) in vivo on platelet closure time in the dog

Journal article

Peer reviewed

The effect of Hetastarch (670/0.75) in vivo on platelet closure time in the dog

L. Smart, K.E. Jandrey, P.H. Kass, J.R. Wierenga and F. Tablin

Journal of Veterinary Emergency and Critical Care, Vol.19(5), pp.444-449

2009

DOI: https://doi.org/10.1111/j.1476-4431.2009.00464.x

Files and links (1)

url

Link to Published Version *Subscription may be requiredView

Abstract

Objective To evaluate the effect of 6% hydroxyethyl starch (HES) solution in vivo, with an average molecular weight of 670 kDa and degree of substitution of 0.75, on canine platelet function. Design Prospective, controlled- experimental study. Setting University of California, Davis, Veterinary Medical Teaching Hospital. Animals Seven healthy employee-owned dogs. Interventions Seven dogs were included in the treatment group. Four of these dogs also served as the control group. Platelet closure time (CT) was measured using a platelet function analyzer and collagen/ADP cartridges. Dogs were given 20 mL/kg of either sodium chloride 0.9% (control group, n=4) or HES (treatment group, n=7) IV over 1 hour. CT was measured before the infusion, and at 1, 3, 5, and 24 hours after the start of the infusion. Measurements and Main Results There was a significant change over time from 0 to 24 hours (P<0.001), a significant difference between groups across time (P<0.001), and a significant group-by-time interaction (P=0.007). At 3 hours, mean CT for the treatment group was 122.3±18.1 seconds, which was significantly different (P<0.001) from the control group (71.0±3.5 s). At 5 hours, mean CT for the treatment group was 142.7±33.9 seconds, which was significantly different (P=0.001) from the control group (75.0±8.6 s). Mean CT at 24 hours was within the reference interval for both the control and treatment group (66.0±2.9 and 81.8±11.9 s, respectively); however, CT in 3 individual dogs in the treatment group at this time point remained prolonged. Conclusions A clinically relevant dose of HES 670/0.75 prolongs CT in dogs for up to 24 hours. This may be due to platelet dysfunction in addition to the effects of hemodilution, and therefore, may increase the risk of bleeding.

Details

Title: The effect of Hetastarch (670/0.75) in vivo on platelet closure time in the dog
Authors/Creators: L. Smart (Author/Creator) - University of California, Davis
K.E. Jandrey (Author/Creator)
P.H. Kass (Author/Creator) - Population Health and Reproduction, and
J.R. Wierenga (Author/Creator) - Veterinary Medical Teaching Hospital
F. Tablin (Author/Creator) - Anatomy, Physiology and Cell Biology,
Publication Details: Journal of Veterinary Emergency and Critical Care, Vol.19(5), pp.444-449
Publisher: Blackwell Publishing Inc.
Identifiers: 991005543700607891
Copyright: © 2009 Veterinary Emergency and Critical Care Society
Murdoch Affiliation: School of Veterinary and Biomedical Sciences
Language: English
Resource Type: Journal article

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Metrics

28 Record Views

41 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.154 Assisted Ventilation; 1.154.360 Procalcitonin
Web Of Science research areas: Veterinary Sciences
ESI research areas: Plant & Animal Science